Sinco Pharmaceuticals Holdings Limited

HKEX:6833.HK

0.184 (HKD) • At close November 5, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.

20232022202120202019201820172016201520142013
Omzet 2,540.0632,271.5052,024.0552,049.8031,176.409952.957806.723858.8941,096.071950.079532.48
Kosten van de omzet 2,216.7831,965.6371,659.1051,775.977956.562849.807738.403754.326943.564820.309471.361
Brutowinst 323.28305.868364.95273.826219.847103.1568.32104.568152.507129.7761.119
Brutowinstmarge 0.1270.1350.180.1340.1870.1080.0850.1220.1390.1370.115
Onderzoek- en ontwikkelingskosten 8.29111.2726.160.8121.5852.0741.9965.0893.0281.7250.77
Algemene en administratieve kosten 108.86280.58565.00140.11945.17855.49757.25662.41940.52417.529.866
Verkoop- en marketingkosten 93.713117.016105.37589.836114.536268.57695.91911.475.7096.7922.358
Verkoop-, algemene en administratieve kosten 202.575204.644172.396130.038161.667325.024153.17573.88946.23324.31212.224
Overige kosten -6.4670.3111.368-3.818-6.174-121.03-39.223-4.459-13.358-7.7150
Bedrijfskosten 205.501195.185177.431132.955157.177340.974232.66672.2859.15431.1349.474
Bedrijfsresultaat 116.46101.224192.554143.78858.18-217.011-84.85530.679106.274105.45848.895
Bedrijfsresultaat ratio 0.0460.0450.0950.070.049-0.228-0.1050.0360.0970.1110.092
Totaal overige inkomsten en kosten netto -16.579-1.932-25.167-7.833-15.225-55.004-110.013-5.113-19.636-11.6462.024
Inkomen voor belasting 99.88199.292167.387135.95542.955-272.015-194.86825.56686.63893.81250.919
Inkomen voor belasting ratio 0.0390.0440.0830.0660.037-0.285-0.2420.030.0790.0990.096
Belastingkosten 57.52929.8332.30417.81819.4058.68.9717.22917.19713.6837.932
Nettowinst 42.35269.462135.083118.13722.898-280.614-185.89619.36769.61469.36736.539
Nettowinstmarge 0.0170.0310.0670.0580.019-0.294-0.230.0230.0640.0730.069
WPA (Winst Per Aandeel) 0.0210.0340.0780.070.014-0.17-0.120.0130.0580.0580.03
Verwaterde WPA 0.0210.0340.0780.070.014-0.17-0.120.0130.0580.0580.03
EBITDA 128.972109.011197.691152.04667.507-206.648-69.60641.277116.503107.33649.901
EBITDA ratio 0.0510.0480.0980.0740.057-0.217-0.0860.0480.1060.1130.094